Skip to content
Medical Health Aged Care

KFSHRC Sets New Global Standards in Digital Healthcare Education

King Faisal Specialist Hospital & Research Centre 2 mins read

4

RIYADH, Saudi Arabia, Aug. 24, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) is leveraging innovative technologies to enhance medical education and training, rolling out ground-breaking initiatives such as the Smart On-Call Room and the Virtual Science Library.

The Smart On-Call Room, powered by STID Mobile ID, has real-time access to critical information, including patient records and clinical guidelines. Streamlining on-call responsibilities significantly reduces response times and enhances the quality of care.

KFSHRC has developed the Virtual Science Library through its Healthcare Information Technology Affairs Department. This comprehensive digital hub offers instant access to the latest medical research, journals, and educational materials, creating an interactive learning environment. This initiative equips staff with the knowledge to navigate the rapidly evolving healthcare landscape. KFSHRC’s advanced simulation-based training programs further enhance the competence and readiness of medical trainees, preparing them to handle real-world scenarios confidently.

Integrating these technologies into everyday practices at KFSHRC reflects the institution's forward-thinking approach and commitment to leveraging digitalization to enhance the educational experience. KFSHRC ensures its educational infrastructure remains at the forefront of technological advancements in medical education and prepares the next generation of Healthcare professionals to excel in an increasingly digital and interconnected world.

These efforts align with global trends in medical education, emphasizing innovation, digital transformation, and global collaboration. As a Gold Sponsor of AMEE 2024, the flagship event of the International Association for Health Professions Education, KFSHRC reinforces its dedication to shaping the future of healthcare education.

It is noteworthy that King Faisal Specialist Hospital & Research Centre has been ranked first in the Middle East and North Africa and 20th globally in the list of the world’s top 250 Academic Medical Centers for the second consecutive year and recognized as the most valuable healthcare brand in Saudi Arabia and the Middle East, according to the 2024 Brand Finance rankings. Additionally, in the same year, Newsweek magazine ranked it among the world's best 250 hospitals.

Media Contact:
Essam AlZahrani
+966 55 525 4429
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/a63fde5b-5da6-4dfa-b3ab-5b88e33566fa


Primary Logo

More from this category

  • Medical Health Aged Care
  • 12/04/2026
  • 07:10
Energy Enhancement System

Court Rules Against Jason Shurka in EESystem Case; $54,034 in Federal Sanctions Ordered

Clark County judge finds defendant’s public statements were not made in good faith. The ruling caps months of legal proceedings brought by the inventor…

  • Contains:
  • Medical Health Aged Care
  • 12/04/2026
  • 06:25
Royal Australian College of GPs

Cleanbill report shows bulk billing rises where funding is strongest, not where competition is greatest

The Royal Australian College of General Practitioners (RACGP) says new Cleanbill data indicates what GPs have consistently warned is true: bulk billing increases where funding better reflects the true cost of care, not where there is greater competition between practices. The Cleanbill report, released today, breaks down bulk billing and gap fees by how rural a practice is based on Modified Monash Model (MM1–7) classification. It shows that the largest increases in 100% bulk billing have occurred in regional and rural areas where government incentives are highest, yet where health department data show there are fewer GPs per person. RACGP…

  • Contains:
  • Biotechnology, Medical Health Aged Care
  • 10/04/2026
  • 11:12
Aravax

Aravax Strengthens Board with Appointments of Carsten Hellmann and Andrew Oxtoby

Aravax, a clinical-stage biotechnology company developing next-generation, disease-modifyingimmunotherapies for food allergy, today announces two additions to its Board of Directors, former CEO of ALK-Abello A/S, Carsten Hellmann and former Chief Commercial Officer of Aimmune Therapeutics, Andrew Oxtoby. Collectively, Carsten and Andrew bring to Aravax exceptionally deep experience from the pharmaceutical industry and, specifically, the allergy therapeutics field. Andrew has deep pharmaceutical industry expertise spanning development, product launch, fundraising and exits from working with large and small companies in the U.S. and Europe. As Chief Commercial Officer he built the global commercial organisation for the approval and launch in the US…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.